ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

December 3, 1993

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

ASCO Supports Tobacco Tax Increase

March 7, 2003

Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too

September 24, 2010

NCI, NCAB o Seek $1.036 billion In ’79; Senate Committee Approves $920 Million for Fiscal ‘78

June 3, 1977